Researching a company's financing exposure means connecting SEC filings: what can issue shares, what has already issued, and how cash needs affect the picture. Dilutracker and AskEdgar both describe tools for this work. The useful comparison is whether each gives you the fields, evidence, and access your research requires.
Dilutracker publishes this comparison. It draws on public product descriptions checked October 31, 2026; we have not performed hands-on benchmarking. The table describes documented capabilities, not measured accuracy or performance. A feature omitted from the reviewed sources should not be read as a feature a product lacks.
Compare the documented workflows
| Research task | Dilutracker | AskEdgar |
|---|---|---|
| Financing and cash | Describes warrants, convertibles, at-the-market programs (ATMs), equity lines, shelf capacity, float, and cash runway in its filing research process. | Lists dilution and offering data, warrant and convertible monitoring, and cash analysis on its product comparison. Its API offering also lists dilution breakdowns, timelines, ratings, float, and shares outstanding. |
| Research and screening | Offers dilution reports and a stock screener through its subscription plans. | Advertises a Studio research agent, filing, news, and earnings summaries, and screeners on its plan page. Confirm the relevant feature's plan access directly. |
| Structured access | Advertises API access with subscription allowances measured in unique tickers per billing month. See its current terms. | Advertises API billing based on returned data volume. See its current API terms and estimate your workload before comparing costs. |
AskEdgar documents meaningful dilution functionality, so a comparison that treats it only as generic filing search misses part of its offering. Product descriptions alone also cannot establish whether either service resolves a particular financing correctly. Use them to define an evaluation, then inspect the evidence.
Evaluate both with the same ticker
The following is a suggested evaluation, not a test we have already run. Keep a small worksheet with each requested field, its value, its effective date, and the source supporting it.
- Choose one ticker and a cutoff date. Use the same share class and research question in both tools. A common cutoff prevents a newer filing in one result from looking like a disagreement about the same evidence.
- Identify the latest periodic report available at that cutoff, then list subsequent financing filings through that date. Keep this document list beside the outputs so you can see whether both answers address the same record.
- Compare outstanding instruments, remaining financing capacity, recent issuance, cash measurement dates, and burn assumptions. Separate registered capacity from completed issuance and proceeds. For runway, check which cash balance and reporting period the calculation uses; a different assumption can produce a different answer without a transcription error.
- Open the source filings and reconcile differences. Check instrument terms, amendments, and dates against each result. Record missing or uncertain values explicitly rather than treating them as zero. If you cannot reconcile a field, keep the uncertainty visible in your research.
Treat a dilution risk rating as a research input, not a prediction that the company will issue shares or that its stock price will move. Ask what evidence supports the rating and whether the underlying facts answer your question.
Check access before subscribing
Confirm your required fields, source traceability, relevant ticker coverage, data freshness, and plan access directly with each provider. Estimate total cost using your expected ticker universe, request frequency, and returned data volume. For any field that matters to your decision, verify that you can inspect its date and supporting evidence in the access level you intend to buy. The most useful comparison is the one you can reproduce for your own workload.